The hemodynamic effects of endothelin receptor antagonism during a venous air infusion in dogs

Endothelin (ET) is involved in the humoral component of the vasoconstriction during pulmonary embolism. We examined the effects of selective ET receptor antagonists on the hemodynamic and respiratory changes and on serum thromboxane B-2 (TXB2) levels, during a continuous venous air infusion (VAI) in anesthetized mongrel dogs. The VAI (0.2 mL . kg(-1) . min(-1)) was initiated 5 min after an injection of saline (controls, n = 7), 1 mu mol of the selective ETA receptor antagonist JKC-301 (group A, n = 6), or 1 mu mol of the selective ETB receptor antagonist BQ-788 (group B, n = 6). Hemodynamic evaluation was performed every 15 min of VAI, and blood samples were drawn for blood gas analysis and TXB2 determinations. The increase in pulmonary perfusion pressure after 30 min of VAI was attenuated in Group A compared with the controls and Group B (Group A = 7 +/- 1 mm Hg; Group B = 16 +/- 1 mm Hg; controls = 14 +/- 1 mm Hg; P < 0.05). Pulmonary vascular resistance showed a similar behavior. TXB2 concentrations increased after 60 min of VAI in the controls and in Group B, but not in Group A (controls = 48%; Group B = 104%; Group A = 18%; P < 0.05 for controls and Group B). Similar decreases in PaO2 and SaO(2) were observed in the three groups. We conclude that antagonism of ETA receptors attenuates the hemodynamic changes and blunts the increase in thromboxane A(2) production during a VAI in dogs. Implications: We evaluated the effects of endothelin receptor antagonists during a venous air infusion in dogs. Endothelin(A) receptor antagonism attenuated the hemodynamic changes and blunted the increase in thromboxane A(2) production in this setting.